High-purity raw materials sourced directly from our ISO-certified manufacturing facilities
Understanding the therapeutic mechanism, market shifts, and procurement strategies for dermatological actives
Perioral Dermatitis (POD) represents an erythematous, papulopustular facial dermatitis that predominantly affects women aged 20–45. Treating POD requires non-irritating, highly specific therapeutic agents that target cutaneous microflora imbalance and follicular hyperkeratinization without disrupting delicate epidermal barrier functions.
Azelaic Acid (Nonanedioic acid, CAS 123-99-9) has emerged globally as a gold-standard active pharmaceutical and cosmetic ingredient for perioral dermatitis and rosacea management. As a naturally occurring saturated dicarboxylic acid, Azelaic Acid exhibits multi-modal action: inhibiting 5-alpha-reductase, neutralizing reactive oxygen species (ROS), suppressing Cutibacterium acnes and Staphylococcus epidermidis density, and normalizing epidermal keratinization.
Global cosmetic and pharmaceutical brands are rapidly pivoting toward multi-functional actives that address sensitive skin conditions without relying on topical corticosteroids, which are known triggers for rebound perioral dermatitis. B2B procurement data shows an annual growth rate of 8.4% for high-purity Azelaic Acid across European and North American markets.
Factories specializing in Azelaic Acid synthesis are currently scaling up micronized and liposomal delivery variants to overcome classical formulation bottlenecks—namely low water solubility, high melting point instability, and grainy crystallization in topical creams.
A trusted designated chemical service provider delivering chemical solutions worldwide
Integrating Azelaic Acid with synergistic functional chemicals for optimal clinical efficacy
Formulating for perioral dermatitis requires restoring the compromised stratum corneum. Combining Azelaic Acid with Sodium L-Pyroglutamate (PCA-Na) and N-Acetyl-D-Glucosamine (CAS 7512-17-6) enhances intercellular lipid synthesis, delivering deep hydration while suppressing localized skin redness.
Azelaic Acid formulations are highly prone to oxidative color degradation. Integrating bio-compatible chelating agents like Sodium Phytate (CAS 14306-25-3) alongside lipid-soluble antioxidants such as Ascorbyl Tetraisopalmitate (CAS 183476-82-6) shields active compounds against radical-induced discolouration and potencies loss.
To reduce tactile grittiness and optimize transdermal penetration of Azelaic Acid without causing stinging in perioral dermatitis patients, factories utilize non-comedogenic ester vehicles like Isopropyl Myristate (CAS 110-27-0) and non-ionic solubilizers like PPG-20 Methyl Glucose Ether (CAS 61849-72-7).
| Parameter / Test Item | Cosmetic Grade Specification | Pharmaceutical Grade (Ph. Eur. / USP) | Analytical Method |
|---|---|---|---|
| Chemical Name | Nonanedioic Acid (Azelaic Acid) | Nonanedioic Acid (Azelaic Acid) | IUPAC Standard |
| CAS Registry No. | 123-99-9 | 123-99-9 | CAS Index |
| Assay (Purity) | ≥ 98.5% (Dry Basis) | 99.0% – 101.0% | HPLC / Titration |
| Melting Point Range | 105.0 °C – 110.0 °C | 106.5 °C – 109.0 °C | Capillary Apparatus |
| Particle Size (D90) | ≤ 45 μm (Standard Fine) | ≤ 15 μm (Ultra-Micronized) | Laser Diffraction (Malvern) |
| Heavy Metals (as Pb) | ≤ 10 ppm | ≤ 5 ppm | ICP-MS |
| Related Impurities | Total ≤ 1.0% | Individual ≤ 0.15%, Total ≤ 0.5% | High-Performance Liquid Chromatography |
Designated Chemical Service Provider & High-End Fine Chemical Manufacturer
Established in 2010, JIMPOCHEM CO., LTD is headquartered in the national-level Chemical Industry Park of Jinan City, Shandong Province. Spanning an expanse of over 500 acres, our state-of-the-art industrial complex seamlessly integrates advanced R&D, automated digital synthesis, rigorous quality control, and global trade logistics.
Our core portfolio centers on high-end fine chemicals, cosmetic active ingredients, pharmaceutical excipients, fluorinated compounds, and performance intermediates. Adhering to the core philosophy that "Quality Leads the Future," JIMPOCHEM operates strictly under ISO 9001 Quality Management and ISO 14001 Environmental Management Systems.
Supported by a technical core team possessing over 16 years of chemical synthesis expertise, we provide one-stop procurement solutions, formulation optimization, and custom synthesis (CMO/CDMO) for over 5,000 corporate clients across 200 countries and regions worldwide.
End-to-end supply chain transparency, quality precision, and eco-friendly chemical innovation
Leveraging deep industrial partnerships and direct raw material integration, JIMPOCHEM maintains stable procurement channels and massive warehouse storage. Our intelligent digital production lines handle multi-ton industrial batches alongside flexible custom orders, ensuring rapid lead times and uninterrupted global delivery.
Every single batch of chemical active leaving our plant undergoes full-spectrum testing via HPLC, GC-MS, FT-IR, and Atomic Absorption Spectrometry. Our comprehensive lot-traceability system allows buyers to verify raw material sources, processing logs, and QA sign-offs via batch QR codes.
In accordance with global dual-carbon strategies, JIMPOCHEM utilizes eco-friendly catalytic synthesis, water-recycling closed circuits, and zero-emission VOC scrubbers. We empower downstream cosmetic and pharma brands to meet strict Scope 1, 2, and 3 sustainability goals.
Overcoming regional trade barriers with complete regulatory documentation and localized technical assistance
Navigating international regulatory frameworks for dermatological raw materials requires expert documentation. JIMPOCHEM supplies full compliance packs for every order, including:
To eliminate shipping delays and geopolitical trade bottlenecks, JIMPOCHEM maintains regional distribution hubs and bonded warehouse reserves across key economic zones in Europe, North America, Southeast Asia, and the Middle East.
Our logistics team specializes in cold-chain logistics, hazardous goods handling (where applicable), custom clearing customs clearance documentation, and flexible Incoterms (FOB, CIF, DDP, DAP).
Pioneering next-generation therapeutic delivery systems and bio-fermentation active routes
Transitioning from classical chemical oxidation of oleic acid to enzymatic microbial fermentation pathways. This eco-friendly route yields ultra-pure Azelaic Acid with zero heavy-metal catalyst residue and a 60% lower carbon footprint.
Developing nanostructured lipid carriers (NLCs) and liposomal encapsulates for Azelaic Acid. This controlled-release technology reduces epidermal contact irritation in perioral dermatitis patients while boosting follicular concentration threefold.
Investigating supramolecular co-crystal complexes combining Azelaic Acid with complementary molecules such as Niacinamide or Tranexamic Acid. Co-crystallization enhances aqueous solubility and structural formulation stability.
Expert technical answers regarding Azelaic Acid sourcing, perioral dermatitis application, and factory workflows
Expand your chemical purchasing portfolio with factory-direct solutions from JIMPOCHEM